DUBOIS, MARCO
 Distribuzione geografica
Continente #
EU - Europa 10.435
NA - Nord America 331
AS - Asia 124
OC - Oceania 2
AF - Africa 1
Totale 10.893
Nazione #
IT - Italia 10.312
US - Stati Uniti d'America 325
SE - Svezia 58
CN - Cina 55
SG - Singapore 24
DE - Germania 15
IN - India 15
FI - Finlandia 12
NL - Olanda 11
GB - Regno Unito 10
FR - Francia 7
HK - Hong Kong 7
CA - Canada 5
TH - Thailandia 4
VN - Vietnam 4
GR - Grecia 3
IE - Irlanda 3
IR - Iran 3
JP - Giappone 3
KR - Corea 3
AU - Australia 2
IL - Israele 2
ES - Italia 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 10.893
Città #
Cagliari 9.817
Uta 448
Boardman 52
Nyköping 48
Fairfield 39
Chandler 35
Ashburn 25
Singapore 15
Houston 14
Shanghai 14
Rome 13
Santa Clara 13
Helsinki 12
New York 12
Seattle 12
Pune 11
San Diego 11
Woodbridge 11
Boston 10
Wilmington 9
Amsterdam 8
Cambridge 6
Los Angeles 6
Munich 5
Toronto 5
Dong Ket 4
Guangzhou 4
Hefei 4
Hong Kong 4
Menlo Park 4
Romainville 4
Clifton 3
London 3
Nakano 3
Peristeri 3
San Cipriano d'Aversa 3
Seoul 3
Delhi 2
Don Mueang 2
Islington 2
Jiaxing 2
Naples 2
Olbia 2
Paris 2
Rosà 2
San Francisco 2
San Giorgio a Cremano 2
Shenzhen 2
Sydney 2
Xian 2
Zhengzhou 2
Alexandria 1
Amgaon 1
Ankara 1
Ann Arbor 1
Bilbao 1
Chandigarh 1
Council Bluffs 1
Dongyang 1
Dublin 1
Exeter 1
Frattamaggiore 1
Hamburg 1
Hangzhou 1
Heidelberg 1
Jacksonville 1
Jinhua 1
Luxembourg 1
Manila 1
Miami Beach 1
Moscow 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Ningbo 1
Norwalk 1
Pisa 1
Piscataway 1
Port-of-spain 1
Portland 1
Pozzuoli 1
Rockville 1
Somerville 1
South Deerfield 1
Stockholm 1
Tabriz 1
Tashkent 1
Tel Aviv 1
Trumbull 1
Washington 1
Wuhan 1
Wuxi 1
Totale 10.762
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.641
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.239
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.105
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 886
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 796
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 729
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 613
Uncovering key targets of success for immunotherapy in pancreatic cancer 596
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 563
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 545
BRCA-mutant pancreatic ductal adenocarcinoma 491
Immune Checkpoint Inhibitors in the Treatment of HCC 489
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 156
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 91
Totale 10.940
Categoria #
all - tutte 16.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 1 330 197 120 40 64 35 70 49 53
2021/20221.147 53 48 3 25 40 84 56 120 69 95 188 366
2022/20232.498 275 375 260 167 184 233 115 157 164 292 182 94
2023/20241.946 79 56 80 107 166 354 365 160 97 97 186 199
2024/20254.390 1.486 1.641 403 463 209 188 0 0 0 0 0 0
Totale 10.940